Home » Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC

Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC

by Jad Chahoud, MD, MPH, MHA | Jun 12, 2025 | Articles | 0 Comments